Nuclear translocation and functions of growth factor receptors

Seminars in Cell and Developmental Biology

Volumn 23, Issue 2, 2012, Pages 165-171

  Mills, Ian G ^a,b  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer; Chromatin; Drug response; Endocytosis; Growth factors; Transcription

Indexed keywords

CELL SURFACE RECEPTOR; EPHRIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; INSULIN RECEPTOR; SOMATOMEDIN C; VASCULOTROPIN RECEPTOR 1;

CELL DIVISION; CELL MIGRATION; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CYTOPLASM; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME ACTIVATION; GENE TRANSLOCATION; GOLGI COMPLEX; NONHUMAN; NUCLEAR TRANSLOCATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84858800071     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.09.004     Document Type: Review

References (85)

1. Mills I.G. The interplay between clathrin-coated vesicles and cell signalling. Semin Cell Dev Biol 2007, 18:459-470.
2. Platta H.W., Stenmark H. Endocytosis and signaling. Curr Opin Cell Biol 2011, 23:393-403.
3. Massie C., Mills I.G. The developing role of receptors and adaptors. Nat Rev Cancer 2006, 6:403-409.
4. Marti U., Burwen S.J., Wells A., Barker M.E., Huling S., Feren A.M., et al. Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology 1991, 13:15-20.
5. Raper S.E., Burwen S.J., Barker M.E., Jones A.L. Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology 1987, 92:1243-1250.
6. Grasl-Kraupp B., Schausberger E., Hufnagl K., Gerner C., Low-Baselli A., Rossmanith W., et al. A novel mechanism for mitogenic signaling via pro-transforming growth factor alpha within hepatocyte nuclei. Hepatology 2002, 35:1372-1380.
7. Dittmann K., Mayer C., Fehrenbacher B., Schaller M., Raju U., Milas L., et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 2005, 280:31182-31189.
8. Xu Y., Shao Y., Zhou J., Voorhees J.J., Fisher G.J. Ultraviolet irradiation-induces epidermal growth factor receptor (EGFR) nuclear translocation in human keratinocytes. J Cell Biochem 2009, 107:873-880.
9. Liccardi G., Hartley J.A., Hochhauser D. EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res 2011, 71:1103-1114.
10. Dittmann K., Mayer C., Fehrenbacher B., Schaller M., Kehlbach R., Rodemann H.P. Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access. Radiother Oncol 2011, 99:317-322.
11. Dittmann K., Mayer C., Fehrenbacher B., Schaller M., Kehlbach R., Rodemann H.P. Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654. FEBS Lett 2010, 584:3878-3884.
12. Dittmann K., Mayer C., Rodemann H.P. Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function. Strahlenther Onkol 2010, 186:1-6.
13. Wanner G., Mayer C., Kehlbach R., Rodemann H.P., Dittmann K. Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. Radiother Oncol 2008, 86:383-390.
14. Das A.K., Chen B.P., Story M.D., Sato M., Minna J.D., Chen D.J., et al. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Res 2007, 67:5267-5274.
15. Lo H.W., Hsu S.C., Ali-Seyed M., Gunduz M., Xia W., Wei Y., et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005, 7:575-589.
16. Huang W.C., Chen Y.J., Li L.Y., Wei Y.L., Hsu S.C., Tsai S.L., et al. Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells. J Biol Chem 2011, 286:20558-20568.
17. Hsu S.C., Miller S.A., Wang Y., Hung M.C. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am J Transl Res 2009, 1:249-258.
18. Furthauer M., Gonzalez-Gaitan M. Endocytic regulation of notch signalling during development. Traffic 2009, 10:792-802.
19. Fortini M.E. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 2009, 16:633-647.
20. Ni C.Y., Yuan H., Carpenter G. Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage. J Biol Chem 2003, 278:4561-4565.
21. Georgakopoulos A., Litterst C., Ghersi E., Baki L., Xu C., Serban G., et al. Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J 2006, 25:1242-1252.
22. Wilhelmsen K., van der Geer P. Phorbol 12-myristate 13-acetate-induced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage events. Mol Cell Biol 2004, 24:454-464.
23. McElroy B., Powell J.C., McCarthy J.V. The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis. Biochem Biophys Res Commun 2007, 358:1136-1141.
24. Kasuga K., Kaneko H., Nishizawa M., Onodera O., Ikeuchi T. Generation of intracellular domain of insulin receptor tyrosine kinase by gamma-secretase. Biochem Biophys Res Commun 2007, 360:90-96.
25. Boulton M.E., Cai J., Grant M.B. gamma-Secretase: a multifaceted regulator of angiogenesis. J Cell Mol Med 2008, 12:781-795.
26. Han J., Ma I., Hendzel M.J., Allalunis-Turner J. The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition. Breast Cancer Res 2009, 11:R57.
27. Brinkmann B.G., Agarwal A., Sereda M.W., Garratt A.N., Muller T., Wende H., et al. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 2008, 59:581-595.
28. Marston D.J., Dickinson S., Nobes C.D. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol 2003, 5:879-888.
29. Ni C.Y., Murphy M.P., Golde T.E., Carpenter G. Gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001, 294:2179-2181.
30. Rio C., Buxbaum J.D., Peschon J.J., Corfas G. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem 2000, 275:10379-10387.
31. Cheng Q.C., Tikhomirov O., Zhou W., Carpenter G. Ectodomain cleavage of ErbB-4: characterization of the cleavage site and m80 fragment. J Biol Chem 2003, 278:38421-38427.
32. Le Gall S.M., Bobe P., Reiss K., Horiuchi K., Niu X.D., Lundell D., et al. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol Biol Cell 2009, 20:1785-1794.
33. Zeng F., Zhang M.Z., Singh A.B., Zent R., Harris R.C. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis. Mol Biol Cell 2007, 18:4446-4456.
34. Muraoka-Cook R.S., Sandahl M.A., Strunk K.E., Miraglia L.C., Husted C., Hunter D.M., et al. ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo. Mol Cell Biol 2009, 29:4935-4948.
35. Vidal G.A., Naresh A., Marrero L., Jones F.E. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities. J Biol Chem 2005, 280:19777-19783.
36. Muraoka-Cook R.S., Sandahl M., Husted C., Hunter D., Miraglia L., Feng S.M., et al. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol Biol Cell 2006, 17:4118-4129.
37. Xu J., Litterst C., Georgakopoulos A., Zaganas I., Robakis N.K. Peptide EphB2/CTF2 generated by the gamma-secretase processing of EphB2 receptor promotes tyrosine phosphorylation and cell surface localization of N-methyl-d-aspartate receptors. J Biol Chem 2009, 284:27220-27228.
38. Litterst C., Georgakopoulos A., Shioi J., Ghersi E., Wisniewski T., Wang R., et al. Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. J Biol Chem 2007, 282:16155-16163.
39. Cai J., Wu L., Qi X., Li Calzi S., Caballero S., Shaw L., et al. PEDF regulates vascular permeability by a gamma-secretase-mediated pathway. PLoS One 2011, 6:e21164.
40. Cai J., Jiang W.G., Grant M.B., Boulton M. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 2006, 281:3604-3613.
41. Aleksic T., Chitnis M.M., Perestenko O.V., Gao S., Thomas P.H., Turner G.D., et al. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res 2010, 70:6412-6419.
42. Sehat B., Tofigh A., Lin Y., Trocme E., Liljedahl U., Lagergren J., et al. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 2010, 3:ra10.
43. Deng H., Lin Y., Badin M., Vasilcanu D., Stromberg T., Jernberg-Wiklund H., et al. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. Biochem Biophys Res Commun 2011, 404:667-671.
44. Johnson H.M., Subramaniam P.S., Olsnes S., Jans D.A. Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays 2004, 26:993-1004.
45. Bryant D.M., Stow J.L. Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor. Traffic 2005, 6:947-954.
46. Bryant D.M., Wylie F.G., Stow J.L. Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. Mol Biol Cell 2005, 16:14-23.
47. Giri D.K., Ali-Seyed M., Li L.Y., Lee D.F., Ling P., Bartholomeusz G., et al. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 2005, 25:11005-11018.
48. Lo H.W., Ali-Seyed M., Wu Y., Bartholomeusz G., Hsu S.C., Hung M.C. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem 2006, 98:1570-1583.
49. Jans D.A., Xiao C.Y., Lam M.H. Nuclear targeting signal recognition: a key control point in nuclear transport?. Bioessays 2000, 22:532-544.
50. Harel A., Forbes D.J. Importin beta: conducting a much larger cellular symphony. Mol Cell 2004, 16:319-330.
51. Myers J.M., Martins G.G., Ostrowski J., Stachowiak M.K. Nuclear trafficking of FGFR1: a role for the transmembrane domain. J Cell Biochem 2003, 88:1273-1291.
52. Hsu S.C., Hung M.C. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J Biol Chem 2007, 282:10432-10440.
53. Lo H.W., Cao X., Zhu H., Ali-Osman F. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res 2010, 8:232-245.
54. Mori T., Ishitani R., Tsukazaki T., Nureki O., Sugita Y. Molecular mechanisms underlying the early stage of protein translocation through the Sec translocon. Biochemistry 2010, 49:945-950.
55. Liao H.J., Carpenter G. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol Biol Cell 2007, 18:1064-1072.
56. Wang Y.N., Yamaguchi H., Huo L., Du Y., Lee H.J., Lee H.H., et al. The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus. J Biol Chem 2010, 285:38720-38729.
57. Offterdinger M., Schofer C., Weipoltshammer K., Grunt T.W. c-erbB-3: a nuclear protein in mammary epithelial cells. J Cell Biol 2002, 157:929-939.
58. Johannes L., Popoff V. Tracing the retrograde route in protein trafficking. Cell 2008, 135:1175-1187.
59. Sandvig K., van Deurs B. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett 2002, 529:49-53.
60. Hampton R.Y. ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 2002, 14:476-482.
61. Wang Y.N., Wang H., Yamaguchi H., Lee H.J., Lee H.H., Hung M.C. COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport. Biochem Biophys Res Commun 2010, 399:498-504.
62. Hieda M., Isokane M., Koizumi M., Higashi C., Tachibana T., Shudou M., et al. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane. J Cell Biol 2008, 180:763-769.
63. Sardi S.P., Murtie J., Koirala S., Patten B.A., Corfas G. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 2006, 127:185-197.
64. Williams C.C., Allison J.G., Vidal G.A., Burow M.E., Beckman B.S., Marrero L., et al. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 2004, 167:469-478.
65. Long W., Wagner K.U., Lloyd K.C., Binart N., Shillingford J.M., Hennighausen L., et al. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 2003, 130:5257-5268.
66. Aqeilan R.I., Donati V., Gaudio E., Nicoloso M.S., Sundvall M., Korhonen A., et al. Association of Wwox with ErbB4 in breast cancer. Cancer Res 2007, 67:9330-9336.
67. Zhu Y., Sullivan L.L., Nair S.S., Williams C.C., Pandey A.K., Marrero L., et al. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res 2006, 66:7991-7998.
68. Arasada R.R., Carpenter G. Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment. J Biol Chem 2005, 280:30783-30787.
69. Sundvall M., Korhonen A., Paatero I., Gaudio E., Melino G., Croce C.M., et al. Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms. Proc Natl Acad Sci U S A 2008, 105:4162-4167.
70. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001, 3:802-808.
71. Lo H.W., Hsu S.C., Xia W., Cao X., Shih J.Y., Wei Y., et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007, 67:9066-9076.
72. Hung L.Y., Tseng J.T., Lee Y.C., Xia W., Wang Y.N., Wu M.L., et al. Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 2008, 36:4337-4351.
73. Hanada N., Lo H.W., Day C.P., Pan Y., Nakajima Y., Hung M.C. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol Carcinog 2006, 45:10-17.
74. de la Iglesia N., Konopka G., Puram S.V., Chan J.A., Bachoo R.M., You M.J., et al. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 2008, 22:449-462.
75. Wang S.C., Lien H.C., Xia W., Chen I.F., Lo H.W., Wang Z., et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 2004, 6:251-261.
76. Massie C.E., Mills I.G. Global identification of androgen response elements. Methods Mol Biol 2011, 776:255-273.
77. Massie C.E., Lynch A., Ramos-Montoya A., Boren J., Stark R., Fazli L., et al. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 2011, 30:2719-2733.
78. Wang S.C., Nakajima Y., Yu Y.L., Xia W., Chen C.T., Yang C.C., et al. Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 2006, 8:1359-1368.
79. Friedmann B.J., Caplin M., Savic B., Shah T., Lord C.J., Ashworth A., et al. Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. Mol Cancer Ther 2006, 5:209-218.
80. Lo H.W., Xia W., Wei Y., Ali-Seyed M., Huang S.F., Hung M.C. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 2005, 65:338-348.
81. Xiang Z., Zeng Z., Tang Z., Fan J., Sun H., Wu W., et al. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J 2009, 15:519-525.
82. Chen Y.J., Huang W.C., Wei Y.L., Hsu S.C., Yuan P., Lin H.Y., et al. Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells. PLoS One 2011, 6:e21428.
83. Noguchi K., Katayama K., Mitsuhashi J., Sugimoto Y. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv Drug Deliv Rev 2009, 61:26-33.
84. Kuroda K., Horiguchi A., Sumitomo M., Asano T., Ito K., Hayakawa M. Activated Akt prevents antitumor activity of gefitinib in renal cancer cells. Urology 2009, 74:209-215.
85. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.